Climb Bio to Present at Upcoming Investor Conferences in September 2025.
PorAinvest
lunes, 25 de agosto de 2025, 7:03 am ET1 min de lectura
CLYM--
The Cantor Global Healthcare Conference will be held in New York on Friday, September 5, 2025, featuring a fireside chat and one-on-one investor meetings. The Baird Global Healthcare Conference will take place on Tuesday, September 9, 2025, also in New York, with a similar format. The Morgan Stanley Annual Global Healthcare Conference, scheduled for Wednesday, September 10, 2025, will consist of one-on-one meetings only. The Stifel Virtual Immunology and Inflammation Forum, also on Wednesday, September 10, 2025, will feature a presentation and one-on-one investor meetings [2].
Climb Bio will provide live webcasts of these events through its investor relations website, with replays available for 30 days after each event. The webcasts can be accessed via the "Investors and News" section of the Climb Bio website [1].
Climb Bio's pipeline includes budoprutug, an anti-CD19 monoclonal antibody with demonstrated B-cell depletion potential, and CLYM116, an anti-APRIL monoclonal antibody currently in IND-enabling studies for IgA nephropathy [1].
References
[1] https://www.stocktitan.net/news/CLYM/climb-bio-to-present-at-upcoming-september-2025-investor-he5rx80touud.html
[2] https://www.globenewswire.com/news-release/2025/08/25/3138331/0/en/Climb-Bio-to-Present-at-Upcoming-September-2025-Investor-Conferences.html
Climb Bio announced its executive team will participate in upcoming investor conferences, including the Cantor Global Healthcare Conference, Baird Global Healthcare Conference, Morgan Stanley Annual Global Healthcare Conference, and Stifel Virtual Immunology and Inflammation Forum. The events will be held in New York and virtually between September 5 and September 10. The live webcasts will be available on Climb Bio's website.
Climb Bio, Inc. (Nasdaq: CLYM), a clinical-stage biotechnology company focused on immune-mediated disease therapeutics, has announced its participation in four major investor conferences in September 2025. The company will attend the Cantor Global Healthcare Conference, Baird Global Healthcare Conference, Morgan Stanley Annual Global Healthcare Conference, and Stifel Virtual Immunology and Inflammation Forum [1].The Cantor Global Healthcare Conference will be held in New York on Friday, September 5, 2025, featuring a fireside chat and one-on-one investor meetings. The Baird Global Healthcare Conference will take place on Tuesday, September 9, 2025, also in New York, with a similar format. The Morgan Stanley Annual Global Healthcare Conference, scheduled for Wednesday, September 10, 2025, will consist of one-on-one meetings only. The Stifel Virtual Immunology and Inflammation Forum, also on Wednesday, September 10, 2025, will feature a presentation and one-on-one investor meetings [2].
Climb Bio will provide live webcasts of these events through its investor relations website, with replays available for 30 days after each event. The webcasts can be accessed via the "Investors and News" section of the Climb Bio website [1].
Climb Bio's pipeline includes budoprutug, an anti-CD19 monoclonal antibody with demonstrated B-cell depletion potential, and CLYM116, an anti-APRIL monoclonal antibody currently in IND-enabling studies for IgA nephropathy [1].
References
[1] https://www.stocktitan.net/news/CLYM/climb-bio-to-present-at-upcoming-september-2025-investor-he5rx80touud.html
[2] https://www.globenewswire.com/news-release/2025/08/25/3138331/0/en/Climb-Bio-to-Present-at-Upcoming-September-2025-Investor-Conferences.html

Divulgación editorial y transparencia de la IA: Ainvest News utiliza tecnología avanzada de Modelos de Lenguaje Largo (LLM) para sintetizar y analizar datos de mercado en tiempo real. Para garantizar los más altos estándares de integridad, cada artículo se somete a un riguroso proceso de verificación con participación humana.
Mientras la IA asiste en el procesamiento de datos y la redacción inicial, un miembro editorial profesional de Ainvest revisa, verifica y aprueba de forma independiente todo el contenido para garantizar su precisión y cumplimiento con los estándares editoriales de Ainvest Fintech Inc. Esta supervisión humana está diseñada para mitigar las alucinaciones de la IA y garantizar el contexto financiero.
Advertencia sobre inversiones: Este contenido se proporciona únicamente con fines informativos y no constituye asesoramiento profesional de inversión, legal o financiero. Los mercados conllevan riesgos inherentes. Se recomienda a los usuarios que realicen una investigación independiente o consulten a un asesor financiero certificado antes de tomar cualquier decisión. Ainvest Fintech Inc. se exime de toda responsabilidad por las acciones tomadas con base en esta información. ¿Encontró un error? Reportar un problema

Comentarios
Aún no hay comentarios